In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675

Journal of Virology

Volumn 76, Issue 11, 2002, Pages 5380-5386

  Molla, Akhteruzzaman ^a   Kati, Warren ^a   Carrick, Robert ^a   Steffy, Kevin ^a   Shi, Yan ^a   Montgomery, Debra ^a   Gusick, Nanette ^a   Stoll, Vincent S ^a   Stewart, Kent D ^a   Ng, Teresa I ^a   Maring, Clarence ^a   Kempf, Dale J ^a   Kohlbrenner, William ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; A 315675; HEMAGGLUTININ; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS RNA; ZANAMIVIR;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; DRUG POTENCY; DRUG RESISTANCE; GENE MUTATION; GENE SEQUENCE; INFLUENZA VIRUS A; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ACETAMIDES; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOGS; DRUG RESISTANCE, VIRAL; ENZYME INHIBITORS; GUANIDINES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; MUTAGENESIS; NEURAMINIDASE; OSELTAMIVIR; PHENOTYPE; PYRANS; PYRROLIDINES; SIALIC ACIDS; VARIATION (GENETICS); ZANAMIVIR;

EID: 0036091649     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.11.5380-5386.2002     Document Type: Article

References (35)

1. BCX-1812: Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design
2. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir
3. In vitro selection and characterization of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir
4. Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity for the neuraminidase-specific inhibitor 4-guanidino-neu5Ac2en
5. The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en
6. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid
7. Mucin and mucoids in relation to influenza virus actin. IV. Inhibition by purified mucoid of infectin and haemagglutinin with the virus strain WSE
8. An oseltamivir treatment-selected influenza A/Wuhan/359/95 virus with an E119V mutation in the neuraminidase gene has reduced infectivity in vivo
9. Phenotypic and genotypic assay of influenza neuraminidase indicate a low incidence of viral drug resistance during treatment with oseltamivir
10. Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en
11. Evidence of zanamivir resistance in an immunocompromised child infected with influenza B virus
12. Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en
13. The action of adamantamines against influenza A viruses: Inhibition of the m2 ion channel protein
14. Emergence and transmission of influenza A viruses resistant to amantadine and rimantidine
15. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections
16. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza
17. In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication
18. GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains
19. Neuraminidase inhibitors as anti-influenza virus agents
20. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: Design, synthesis, and structural analysis of carbocyclic acid analogues with potent anti-influenza activity
21. Resistance of influenza viruses to neuraminidase inhibitors - A review
22. Generation and characterization of variants of NWS/G70c influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu-5Ac2en
23. Mutations in a conserved residue in the influenza virus neuraminidase active site decrease sensitivity to Neu5Ac2en-derived inhibitors
24. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS4071 protects mice and ferrets against influenza infection
25. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses
26. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase
27. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): Mechanism of action
28. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
29. Selection of influenza virus with reduced sensitivity in vitro to the neuraminidase inhibitor GG167 (4-guanidino-Neu5A2en): Changes in haemagglutinin may compensate for loss of neuraminidase activity
30. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor
31. Molecular basis of resistance of influenza viruses to 4-guanidino-Neu5Ac2en
32. Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS4071
33. Dihydropyrancarboxamides related to zanamivir: A new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus type A and B
34. Three dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase
35. Nucleotide sequence of the haemagglutinin gene of a human influenza virus HI subtype